Product Description

Tacrolimus IP 5 mg is an immunosuppressive formulation developed to support organ transplant management and immune response regulation under medical supervision. The formulation is commonly used to help prevent organ rejection in patients undergoing kidney, liver, heart, or other organ transplantation procedures. By controlling the body’s immune response, Tacrolimus helps improve transplant acceptance and supports long-term graft survival and patient outcomes.

The immune system naturally identifies transplanted organs as foreign tissues and may attempt to attack them, leading to organ rejection. Tacrolimus works by suppressing specific immune activities responsible for triggering rejection responses. This action helps protect transplanted organs and supports stable post-transplant recovery and long-term transplant management.

Tacrolimus belongs to a class of medicines known as calcineurin inhibitors. It works by reducing the activity of certain immune cells and inhibiting the production of substances involved in immune system activation. This mechanism helps control excessive immune reactions and supports effective immunosuppressive therapy.

The formulation may also be prescribed in selected autoimmune and inflammatory conditions as advised by healthcare professionals. Treatment typically requires careful dosage management and regular monitoring to maintain therapeutic effectiveness while minimizing potential complications associated with immune suppression.

Manufactured under stringent WHO-GMP quality standards, the formulation is produced using advanced pharmaceutical technologies and undergoes comprehensive quality testing to ensure purity, safety, efficacy, and pharmaceutical consistency. Every batch is carefully monitored to maintain dependable therapeutic performance and high-quality healthcare standards.

Key Features

• Supports organ transplant management
• Helps prevent transplant rejection
• Effective immunosuppressive formulation
• Reliable and consistent therapeutic performance
• Manufactured under strict WHO-GMP standards
• Produced using advanced pharmaceutical processes
• Quality-assured formulation for safe usage

Uses

• Organ transplant rejection prevention
• Immunosuppressive therapy support
• Post-transplant management
• Selected autoimmune condition management under medical supervision

How It Works

Tacrolimus works by suppressing immune system activity responsible for organ rejection. It inhibits specific immune responses and reduces the activity of immune cells that may attack transplanted organs.

Possible Side Effects

Common side effects may include:

• Headache
• Tremors
• Nausea
• Increased blood pressure
• Kidney function changes
• Increased susceptibility to infections
• Elevated blood sugar levels

Patients should seek immediate medical attention if severe allergic reactions, breathing difficulty, unusual swelling, or signs of serious infection occur.

Precautions

• Use only under strict medical supervision
• Regular monitoring of kidney function and blood levels may be required
• Avoid exposure to infections during treatment
• Inform your doctor about existing medical conditions or medications
• Avoid self-medication or dosage adjustments without professional advice

Storage Instructions

Store in a cool, dry place away from direct sunlight, heat, and moisture. Keep out of reach of children and use before the expiry date mentioned on the packaging.

Quality Assurance

Manufactured in WHO-GMP certified facilities, the formulation undergoes stringent quality control procedures and comprehensive testing to ensure safety, efficacy, purity, and dependable therapeutic performance.